期刊文献+

上皮性卵巢癌患者术前血小板增多的临床意义 被引量:1

the clinical value of higher platelete in preoperative patients with epithilial ovarian cancer
下载PDF
导出
摘要 目的探讨上皮性卵巢癌患者术前PLT计数增高的临床意义。方法选择临床明确诊断的上皮性卵巢癌患者93例(卵巢癌组)、卵巢良性疾病患者40例(卵巢良性疾病组)及健康体检者40例(健康对照组)。取患者术前晨起空腹静脉血检测血小板(PLT)计数及血清CA125水平,结合临床资料进行统计分析。结果卵巢癌组PLT计数为277.6±96.2(×109/L),PLT计数升高47例(41.8%),均明显高于卵巢良性疾病组和健康对照组,差异有统计学意义(P<0.05)。晚期上皮性卵巢癌患者PLT计数明显高于早期患者(P<0.005)。淋巴结转移的晚期上皮性卵巢癌患者PLT计数显著高于无淋巴结转移者(P<0.005)。晚期上皮性卵巢癌患者PLT计数与血清CA125水平具有正相关性,(r=0.540,P<0.01)有统计学意义。结论 PLT计数增高可作为判断术前上皮性卵巢癌患者不良预后的指标之一。 Aim To investigate the clinical value of higher platelete in preoperative patients with epithilial ovarian cancer.Methods The study included the ovarian cancer group(n=93),benign ovarian diseases group(n=40) and healthy control group(n=40).The platelete and serum CA125 were measured in the study groups.The data would be analyzed combing with the clinical information.Results The platelete count was higher in ovarian diseases group((277.6±96.2)×109/L) than in benign ovarian diseases group and healthy control group,there was significance statisitical difference(P<0.05).The platelete count was higher in late-ovarian patients than that in pre-ovarian patients.The platelete count was higher in late-ovarian patients with lymphonodus metastasis than that without lymphonodus metastasis patients.The platelete count was correlation to the serum CA125(r=0.54,P<0.01).Conclusion The higher platelete count may be a prognostic marker in the patients with epithilial ovarian cancer.
出处 《临床检验杂志(电子版)》 2013年第2期343-344,339,共3页 Clinical Laboratory Journal(Electronic Edition)
关键词 上皮性卵巢癌 血小板计数 转移 epithelia l ovarian carc inom a platelet count Metastasis
  • 相关文献

参考文献5

  • 1徐长娟,谭文华,胡春宇,张晓玉,石蕾.晚期卵巢上皮性癌与血小板计数增高相关性的临床分析[J].齐齐哈尔医学院学报,2011,32(18):2918-2919. 被引量:3
  • 2齐璇,辛晓燕.卵巢恶性肿瘤与血小板增多关系的临床研究[J].现代妇产科进展,2004,13(3):187-189. 被引量:12
  • 3Min Soon Cho,Justin Bottsford-Miller,Hernan G. Vasquez.Platelets increase the proliferation of ovarian cancer cells[].Blood.2012
  • 4RL Stone,AM Nick,IA McNeish,F Balkwill,HD Han,J Bottsford-Miller,R Rupaimoole,GN Armaiz-Pena,CV Pecot,J Coward,MT Deavers,HG Vasquez,D Urbauer,CN Landen,W Hu,H Gershenson,K Matsuo,MM Shahzad,ER King,I Tekedereli,B Ozpolat,EH Ahn,VK B.Paraneoplastic thrombocytosis in ovarian cancer[].The New England Quarterly.2012
  • 5Friebe Zbigniew,Watrowski Rafa?,Bembnista Maciej,Rokowska Anita,W?osiińska Joanna,Dembińska Ma?gorzata.[Correlation between platelet count and CA-125 in ovarian cancer][].Ginekologia Polska.2005

二级参考文献11

  • 1陈洁.血小板计数与晚期上皮性卵巢癌患者疾病进程和二次开腹探查结果的关系[J].国外医学(妇产科学分册),2005,32(2):130-130. 被引量:4
  • 2徐志文 黄光武 等.头颈恶性肿瘤浸润转移的凝血纤溶因素[J].耳鼻咽喉:头颈外科,1999,6(5):318-320.
  • 3Watanabe Y, Nakai H, Ueda H, et al. Platelet-derived endothe-lial cell growth factor predicts of progression and recurrence in primary epithelial ovarian cancer [J]. Cancer Lett, 2003,200 (2):173-176.
  • 4Li AJ, Madden AC, Cass I, et al. The prognostic significance of thrombocytosis in epithelial ovarian carcinoma[J]. Gynecol On -col,2004,92(1) :211-214.
  • 5Menczer J, Schejter E, G eva D, et al. Ovarian carcinoma associated thrombocytosis. Correlation with prognostic factors and with survival[J] .Eur J Gynaecol Oncol, 1998,19:82-84
  • 6Watanabe Y, NakaiH, NozakiK, et al. Platelet-derived endothelial cell growth factor predict of progression and recurrence in primary epithelial ovarian cancer[J]. Cancer Lett,2003,200:173-176
  • 7Furuhashi M, Miyabe Y, Oda H. A case of thrombopoietinproducing ovarian carcinoma confirmed by immunohistochemistry[J]. Gynecol Oncol, 1999,74:278-281
  • 8Gastl G, Plante M, Finstad CL,et al. High IL-6 levels in ascitic correlate with reactive thrombocytosis in patients with epithelial ovarian cancer[ J]. Br J Haematol, 1993,83:433-441
  • 9Salgado R, Benoy I, Weytjens R, et al. Arterio-venous gradients of IL-6, plasma and serum VEGF and D-dimers in human cancer[J]. Br J Cancer, 2002,87:1437-1444
  • 10张培彤,裴迎霞,朴炳奎,孙桂芝,林红生,祁鑫.肿瘤患者与正常人血小板表面粘附蛋白表达异同的临床观察及意义[J].中华肿瘤杂志,1998,20(3):207-209. 被引量:66

共引文献13

同被引文献20

  • 1蒋维洪,陈士民.晚期卵巢上皮性癌与血小板计数增高相关性分析[J].肿瘤学杂志,2006,12(3):237-238. 被引量:5
  • 2GayLJ,Felding HabermannB.Contributionofplateletstotumormetastasis[J].NatRevCancer,2011,11(2):123-134.
  • 3GungorT,KanatPektasM,SucakA,etal.Theroleofthrombocy-tosisinprognosticevaluationofepithelialovariantumors[J].ArchGynecolObstet,2009,279(1):53-56.
  • 4Stone R L,Nick A M,McneishI A,etal.Paraneoplasticthrombocytosisinovariancancer[J].NEnglJMed,2012,366(7):610-618.
  • 5Cho M S,Bottsford MilerJ,VasquezH G,etal.Plateletsin-creasethe proliferation ofovarian cancercells[J].Blood,2012,120(24):4869-4872.
  • 6HolmesCE,LevisJE,OrnsteinD L.Activatedplateletsen-hanceovariancancercellinvasioninacellularmodelofmetas-tasis[J].ClinExp Metastasis,2009,26(7):653-661.
  • 7CrastaJA,PremlathaTS,KrishnanS M,etal.Significanceofpreoperativethrombocytosisinepithelialovariancancer[J].IndianJPatholMicrobiol,2010,53(1):54-56.
  • 8LiuQ,JerniganD,ZhangY,etal.Implicationofplatelet-de-rivedgrowthfactorreceptoralphainprostatecancerskeletalmetastasis[J].ChinJCancer,2011,30(9):612-619.
  • 9KuoYC,SuCH,LiuCY,etal.Transforminggrowthfactor-betainducesCD44cleavagethatpromotesmigrationofMDA-MB-435scellsthroughtheup-regulationofmembranetype1-matrixmetalloproteinase [J].IntJCancer,2009,124(11):2568-2576.
  • 10St HillC A.Interactionsbetweenendothelialselectinsandcancercellsregulatemetastasis[J].FrontBiosci(LandmarkEd),2011,16:3233-3251.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部